Latest filing published 12 Aug 2026 for Treace Medical Concepts, INC..
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
All filings by Mark Hair on record concern Treace Medical Concepts, Inc., in the capacity of finance chief. In total, 23 filings cover trades dated from 27 April 2021 to 9 August 2026.
Market trades split into 3 purchases (€285k) and 1 sale (€24k). Taken together, the purchases exceed the sales by €261k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 19 share grants.
In size, the median ticket on the buying side is €94k. 2 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
On 12 August 2026 came the latest disclosure, a share grant in Treace Medical Concepts, Inc. The last purchase on record was published on 20 May 2022, which is 1,620 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations